Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cilostazol on Simvastatin and Pravastatin Disposition
NCT02431013Phase 1Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Apr 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cilostazol in peripheral artery disease (PAD) and dyslipidemia (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Area Under the Curve of Simvastatin at 12 hours. Status: unknown.
02
Drugs
cilostazol
03
Conditions
peripheral artery disease (PAD)dyslipidemia
Beyond the preview
Go deeper on NCT02431013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431013.